Who owns Selecta Biosciences?
- Ticker: RNAC
- CUSIP Number: 816212104
Tip: Access positions for across all investors
Analyze quarterly positions in Selecta Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Selecta Biosciences stock
Who bought or sold Selecta Biosciences this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 14M | $9.3M | 459% | Mar 2024 |
|
| Artal Group | 9.1M | $5.9M | 0% | Mar 2024 |
|
| BlackRock | 7.3M | $4.7M | -6% | Mar 2024 |
|
| Vanguard Group | 6.3M | $4.1M | -13% | Mar 2024 |
|
| Geode Capital Management | 2.5M | $1.7M | 5% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.4M | $926k | -4% | Mar 2024 |
|
| Goldman Sachs Group | 1.2M | $23M | -21% | Mar 2024 |
|
| Millennium Management | 995k | $647k | 361% | Mar 2024 |
|
| Northern Trust | 936k | $608k | -1% | Mar 2024 |
|
| Delphi Financial | 661k | $430k | 0% | Mar 2024 |
|
| Madison Avenue Partners | 583k | $402k | -85% | Dec 2023 |
|
| Nuveen Asset Management | 490k | $319k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 325k | $212k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 317k | $206k | -5% | Mar 2024 |
|
| Bridgeway Capital Management | 306k | $199k | -33% | Mar 2024 |
|
| CM Management | 306k | $199k | -56% | Mar 2024 |
|
| Morgan Stanley | 221k | $144k | 28% | Mar 2024 |
|
| Jane Street | 190k | $124k | 122% | Mar 2024 |
|
| Ironwood Investment Management | 177k | $115k | 4% | Mar 2024 |
|
| Rhumbline Advisers | 130k | $84k | 2% | Mar 2024 |
|
| Barclays | 119k | $78k | -41% | Mar 2024 |
|
| UBS Group | 117k | $76k | -11% | Mar 2024 |
|
| Citadel Advisors | 116k | $76k | -78% | Mar 2024 |
|
| Squarepoint Ops | 109k | $71k | -38% | Mar 2024 |
|
| Royal Bank of Canada | 67k | $44k | -42% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 66k | $43k | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 59k | $38k | 72% | Mar 2024 |
|
| American International | 58k | $40k | 1% | Dec 2023 |
|
| Laurie Hall | 53k | $34k | 0% | Mar 2024 |
|
| SG Americas Securities | 47k | $31k | -53% | Mar 2024 |
|
| Ing Investment Management | 46k | $30k | -8% | Mar 2024 |
|
| Susquehanna International | 45k | $29k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 45k | $29k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 40k | $26k | 14% | Mar 2024 |
|
| Bank of America Corporation | 36k | $24k | -81% | Mar 2024 |
|
| Alerus Financial | 30k | $20k | 0% | Mar 2024 |
|
| Belpointe Asset Management | 28k | $19k | 8% | Mar 2024 |
|
| Sphera Funds Management | 25k | $489k | -97% | Mar 2024 |
|
| Dimensional Fund Advisors | 24k | $16k | 0% | Mar 2024 |
|
| Citigroup | 22k | $14k | 13% | Mar 2024 |
|
| ProShare Advisors | 21k | $13k | -18% | Mar 2024 |
|
| Alliancebernstein | 17k | $12k | 0% | Dec 2023 |
|
| Victory Capital Management | 14k | $8.8k | -10% | Mar 2024 |
|
| Graham Capital Management | 13k | $8.6k | -16% | Mar 2024 |
|
| Engineers Gate Manager | 13k | $8.2k | 100% | Mar 2024 |
|
| Principal Financial Group | 12k | $8.0k | -21% | Mar 2024 |
|
| Legal & General Group | 12k | $7.6k | 0% | Mar 2024 |
|
| Lazard Asset Management | 11k | $0 | -5% | Dec 2023 |
|
| WNY Asset Management | 10k | $6.7k | 0% | Mar 2024 |
|
| Journey Advisory Group | 10k | $6.5k | -33% | Mar 2024 |
|
| Summit Investment Advisors | 9.6k | $6.2k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 7.1k | $4.6k | -21% | Mar 2024 |
|
| Tower Research Capital | 7.1k | $4.6k | -37% | Mar 2024 |
|
| California State Teachers Retirement System | 6.1k | $4.0k | -76% | Mar 2024 |
|
| Amalgamated Bank | 3.9k | $3.0k | -67% | Mar 2024 |
|
| Newbridge Financial Services Group | 3.0k | $2.0k | 0% | Mar 2024 |
|
| Group One Trading | 2.8k | $1.8k | -33% | Mar 2024 |
|
| Cutler | 1.7k | $999.940000 | 0% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 1.3k | $872.022000 | 0% | Dec 2023 |
|
| Hazlett, Burt & Watson | 381.00 | $0 | 0% | Mar 2024 |
|
| Russell Investments | 211.00 | $137.002300 | 0% | Mar 2024 |
|
| FNY Investment Advisers | 100.00 | $1.0k | 100% | Mar 2024 |
|
| Capital Advisors | 80.00 | $0 | 100% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Selecta Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Nantahala Capital Management | Dec 2023 | 2.2M | $1.5M |
| Ameriprise Financial | Sep 2023 | 405k | $429k |
| Tang Capital Management | Dec 2023 | 400k | $276k |
| GSA Capital Partners | Dec 2023 | 135k | $93k |
| Virtu Financial | Dec 2023 | 89k | $61k |
| XTX Topco | Sep 2023 | 85k | $90k |
| MetLife Investment Advisors | Sep 2023 | 62k | $66k |
| Personal Cfo Solutions | Sep 2023 | 55k | $58k |
| Florida State Board of Administration | Dec 2023 | 31k | $21k |
| T. Rowe Price Associates | Dec 2023 | 27k | $19k |
| HighTower Advisors | Dec 2023 | 25k | $17k |
| William Blair $ Company | Dec 2023 | 25k | $17k |
| Hrt Financial | Dec 2023 | 15k | $10k |
| Metropolitan Life Insurance Company | Sep 2023 | 7.1k | $7.5k |
| Farther Finance Advisors | Dec 2023 | 1.1k | $372.017800 |
| Parallel Advisors | Dec 2023 | 200.00 | $69.000000 |